OTC Markets OTCPK - Delayed Quote USD

bioMérieux S.A. (BMXXY)

9.51
0.00
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,979,900
3,979,900
3,674,600
3,589,000
3,376,200
Cost of Revenue
1,764,600
1,764,600
1,617,400
1,580,400
1,375,400
Gross Profit
2,215,300
2,215,300
2,057,200
2,008,600
2,000,800
Operating Expense
1,577,400
1,577,400
1,488,300
1,382,900
1,156,800
Operating Income
637,900
637,900
568,900
625,700
844,000
Net Non Operating Interest Income Expense
-19,100
-19,100
-14,200
-5,200
-6,100
Pretax Income
579,300
579,300
437,500
580,500
774,500
Tax Provision
154,300
154,300
114,500
140,100
175,600
Net Income Common Stockholders
432,200
432,200
357,600
452,400
601,100
Diluted NI Available to Com Stockholders
432,200
432,200
357,600
452,400
601,100
Basic EPS
0.37
0.37
0.30
0.38
0.51
Diluted EPS
0.36
0.36
0.30
0.38
0.51
Basic Average Shares
1,179,214.98
1,179,214.98
1,181,542.33
1,179,461.46
1,182,653.77
Diluted Average Shares
1,187,682.81
1,187,682.81
1,188,024.62
1,184,406.01
1,188,932.89
Total Operating Income as Reported
588,800
588,800
439,000
587,200
784,300
Total Expenses
3,342,000
3,342,000
3,105,700
2,963,300
2,532,200
Net Income from Continuing & Discontinued Operation
432,200
432,200
357,600
452,400
601,100
Normalized Income
465,670.40
465,670.40
453,244.80
485,037
649,274.91
Interest Income
500
500
1,100
1,200
1,700
Interest Expense
16,000
16,000
15,800
4,100
9,100
Net Interest Income
-19,100
-19,100
-14,200
-5,200
-6,100
EBIT
595,300
595,300
453,300
584,600
783,600
EBITDA
897,500
897,500
712,200
832,600
1,031,400
Reconciled Cost of Revenue
1,764,600
1,764,600
1,617,400
1,580,400
1,375,400
Reconciled Depreciation
302,200
302,200
258,900
248,000
247,800
Net Income from Continuing Operation Net Minority Interest
432,200
432,200
357,600
452,400
601,100
Total Unusual Items Excluding Goodwill
-45,600
-45,600
-129,600
-43,000
-62,300
Total Unusual Items
-45,600
-45,600
-129,600
-43,000
-62,300
Normalized EBITDA
943,100
943,100
841,800
875,600
1,093,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-12,129.60
-12,129.60
-33,955.20
-10,363
-14,125.09
12/31/2021 - 8/1/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESF.VI Eurofins Scientific SE
56.42
-0.04%
 
LO3A.BE Lonza Group Ltd
61.50
-0.81%
 
LO3A.F Lonza Group AG
61.50
+1.65%
 
LO3.MU Lonza Group Ltd
607.00
-3.68%
 
LZAGF Lonza Group AG
707.35
-4.41%
 
QTS.F IQVIA Holdings Inc.
136.60
+1.11%
 
LZAGY Lonza Group AG
69.14
-1.69%
 
ERF.PA Eurofins Scientific SE
56.12
-0.64%
 
LONN.SW Lonza Group AG
571.20
-1.14%
 
IQV IQVIA Holdings Inc.
153.29
-0.01%